-Built and leading new national team with goal to optimize market awareness of rare disease portfolio of products (recruitment, hiring, training, driving executional alignment)-Key Opinion Leader engagement/partnership initiatives (Pediatric and Adult Hematologists, Ophthalmologists)-Preparing launch executional plans, such as sales team training, sales targeting, Specialty Pharmacy partnership evaluation, pre-launch disease education, and product pull through preparedness-Lead Specialty Pharmacy QBRs and collaborate closely on product pull through -Evaluate, discuss, align on organizational policies and procedures with cross-functional stakeholders (Legal, Marketing, Medical, Executive Leadership), given recent merger and subsequent new ways of operating.

• Led national field team efforts related to education, testing (genetic and biochemical), and treatment of Chronic Granulomatous Disease, an ultra-rare, genetically inherited immune deficiency; focus includes immunology, infectious disease, hematology, transplanters• Reversed trajectory and expectation for declining net revenue, stabilized the brand’s financial performance, along with exceeded forecast in 2019, 2020, 2021, achieved highest net sales in history of brand in 2022• Leader of the Year nominations: 2020, 2021, 2022• Led cross functional team (Trade, Sales/Marketing, Patient Services) in evaluating and establishing access to Horizon’s medicines in Puerto Rico• Led cross functional team (Medical, Sales/Marketing, Leadership) in evaluating genetic testing commercial labs and, ultimately, contracting to establish partnership for company sponsored genetic testing program• Harness relationships and partner closely with key opinion leaders, advocacy organizations, and academic centers• Coordinate closely with organizational partners such as Marketing, Patient Services, Patient Advocacy, Training, Analytics, on business strategy and execution initiatives• Led Life Cycle Management (LCM) project to assess long term plan and opportunities for the Brand• Work cross functionally to implement new data sources (lab data, ICD-10 data) to strengthen patient finding efforts

Assisted in build of sales force and infrastructure for the company's first commercial product launch in ultra-orphan marketplace of Familial Chylomicronemia Syndrome (FCS)-Recruited, hired, and lead team in educating lipid specialists, endocrinologists, gastroenterologists on signs and symptoms, phenotypic diagnosis criteria, and educational resources for this life threatening, lipid disorder previously not well understood -Significant efforts spent on triangulating data sources and market intel to effectively target to increase proper diagnosis -Regional Director lead of several cross-functional teams, such as Marketing Field Advisory Board and Business Operations Champions, aimed at providing strategic input on business analytics tools, diagnostic resources, and provider/patient education-Collaborate closely with Patient Advocacy in organizing and executing patient meetings geared towards connecting patients with others living with this rare disease to reduce isolation, and increase disease knowledge, empowerment, and advocacy

Led team of 9 Clinical Specialists in promotion of Esbriet for Idiopathic Pulmonary Fibrosis (IPF), a rare and fatal, lung disease-Team Achievement: 3rd highest market share, 2nd highest new patient share, and least competitor-only prescribers in country-Division Manager sponsor of Interstitial Lung Disease (ILD) Focus Group focusing on sharing of KOL insights and best practices in ILDs-Identified need for clinical education and partnering for clinical management with Specialty Pharmacies and presented findings/action plan to Senior Management, which resulted in national initiative focused on these areas -Led team through a major sales force expansion, including managing significant account disruption and hiring processes

Led team of nine Clinical Specialists: responsibilities included Actemra (Intravenous and Subcutaneous Injection) and Rituxan (Intravenous Injection) for rheumatoid arthritis, granulomatosis polyangiitis, and microscopic polyangiitis-2015 Excellence Win, 2015 Key Contributor Award-2014 Winner of Peer MVP Award, as nominated and selected by Division Manager counterparts; 2014 Key Contributor Award-2013 Excellence Win, 2013 Key Contributor Award-Presented economics and gained Senior Leadership advocacy to contract with large, local payor plan, which resulted in removal of step-edit-Served up strategy to alter field structure to Senior Leaders emphasizing analysis on hospital business opportunities. Gained approval to create and implement unique role of Institutional Account Representative -2015 sponsor of Franchise Clinical Specialist Team, 2014 sponsor of Compliance Captain Team, 2011/2012 sponsor of Rituxan Key Account Specialist Team: All teams dedicated to elevating performance and increasing communication

Supported Region Sales Director and Division Managers on business strategy, tactical execution, and data analysis-Created and led the roll out of a novel analytics tool designed to conceptualize goal attainment and quantify account opportunity-Consulted and strategized with clinical specialists on account targeting tactics and selling opportunities -Partnered with home office departments, such as Sales Operations Management, Marketing, Training, Sales Management -Enhanced communication, created a community, and increased exposure of people within the Region across the greater organization as Editor in Chief of the Region’s quarterly newsletter

Responsible for launching and promoting a novel infusible biologic, ACTEMRA (tocilizumab), in the Philadelphia academic institutions and New Jersey in-office infusion accounts-2011 Key Contributor Award-Interim Division Manager July 2010 through January 2011-2010 Winner of Regional Best in Class Award, Divisional Best in Class Award, Peer MVP, and Sales Excellence Award-2009 Winner of Peer MVP Award, as nominated and selected by division teammates-2008 Winner of Sales Excellence Award (SEA) -Launched Systemic Juvenile Idiopathic Arthritis indication in Philadelphia Children’s Hospitals-Piloted Region Program Manager position assisting Region Sales Director with data analytics and Region initiatives-2008, 2009, 2010 District Sales Trainer: Active in coaching representatives on clinical and business acumen -Communicated coding, Specialty Pharmacy, and payor policy specifics, including complexities of miscellaneous J-code -Field Advisory Board to Immunology V.P. (GIOFAB), Marketing Advisory Committee (PAC), and Access Solutions Liaison

Responsible for launching and promoting Orencia (abatacept), an intravenous biologic, in hospital and in-office infusion settings-2008 Pioneer of Distinction-At exit ranked #1 in nation, 1Q08 sales goal achievement of 250%-2008 ranked #5 in nation, #1 in Region and District; Incentive Compensation achievement of 204% -Winner of the 2007 Regional Business Director Award-During launch year, drove product trial to 92% of targeted rheumatologists-Communicated complex billing and reimbursement scenarios, especially at launch with a miscellaneous J-code-Coordinated with Reimbursement Specialist, Payor Account Executives, Specialty Pharmacy Providers, Home Infusion Agencies, and distributors to identify and resolve issues pertaining to product acquisition and reimbursement

Responsible for promoting Abilify, an antipsychotic indicated for schizophrenia and bipolar disorder, within in the hospital setting-2005 Pinnacle Winner-2005 Incentive Compensation achievement of 217%, up from 55% in October of 2004 when started in territory-Winner of eight Region month over month of share change contests-Gained formulary position of Abilify’s injectable formulation at seven institutions-Trained two new representatives on product, disease state, and territory knowledge

Responsible for promoting Plavix (antiplatelet therapy), Pravachol (cholesterol lowering agent), and Monopril (hypertensive treatment) to Cardiologists, Family Practioners, Internists, Endocrinologists, and Vascular Surgeons-2004 Pinnacle Winner-Improved 2003 Pinnacle Ranking to #5/35 from #18/35; 2003 YTD ranking 8/35, 2003 Incentive Compensation at 161%-Recognized by Region for product/disease state knowledge and selected for the Plavix Marketing national training video -Mentored and trained new Plavix representative, as the Plavix Peripheral Arterial Disease lead for the Livingston District

Financial Leadership ProgramOne of 27 candidates selected from over 1,000 applicants to participate in AT&T’s Financial Leadership Program (FLP), a two year executive development program within AT&T’s Finance organization that offers individuals the opportunity to develop leadership, improve finical and technical skills, and enhance personal effectiveness at an accelerated paceBusiness Case/Product Analyst, AT&T Consumer Services March 2002 – October 2002• Created forecasting models to determine the financial impacts of marketing promotions on AT&T’s WorldNet, Digital Subscriber Line (DSL), and Local Services product profitability• Partnered with Marketing and Product Management to define business case assumptions and review analysis resultsInvestor Relations Manager, AT&T Broadband September 2001-March 2002-Collaborated with Executive Team in anticipation of Earnings Announcements and analyst conferences by preparing guidance and earnings release documentation that properly positioned company financial and operational results-Researched and analyzed industry trends and analyst models to benchmark company performance strategyBusiness Controls Manager, AT&T Business Services March 2001-September 2001-Core member of team responsible for improving end-to-end contracting process flows by identifying operational break-downs that result in customer billing discrepancies-Led over 80 interviews with individuals from the Sales organization, reviewed customer contracts and correspondence pertaining to billing errors, and then identified, documented, and presented findings to senior managementProcurement Manager, AT&T Supplier Management Division August 2000- March 2001-Negotiated multi-million dollar facilities management outsourcing contract resulting in $15M savings in first year-As Supplier’s single-point of contact, led bidder’s conferences to communicate requirements and field questions